0001484612-22-000004.txt : 20220104
0001484612-22-000004.hdr.sgml : 20220104
20220104162954
ACCESSION NUMBER: 0001484612-22-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trigg Leslie
CENTRAL INDEX KEY: 0001304125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 22506483
MAIL ADDRESS:
STREET 1: C/O OUTSET MEDICAL
STREET 2: 1830 BERING ROAD
CITY: SAN JOSE
STATE: CA
ZIP: 95112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-01-03
0
0001484612
Outset Medical, Inc.
OM
0001304125
Trigg Leslie
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
1
1
0
0
Chief Executive Officer
Common Stock
2022-01-03
4
M
0
20000
3.88
A
270567
D
Common Stock
2022-01-03
4
S
0
20000
47.0976
D
250567
D
Common Stock
2022-01-03
4
M
0
12500
3.88
A
263067
D
Common Stock
2022-01-03
4
S
0
12500
47.0996
D
250567
D
Common Stock
2022-01-03
4
M
0
10000
3.88
A
260567
D
Common Stock
2022-01-03
4
S
0
10000
47.0866
D
250567
D
Common Stock
8770
I
Trigg Family Trust
Non-Qualified Stock Option (right to buy)
3.88
2022-01-03
4
M
0
20000
0.0
D
2027-09-19
Common Stock
20000
138211
D
Non-Qualified Stock Option (right to buy)
3.88
2022-01-03
4
M
0
12500
0.0
D
2027-09-19
Common Stock
12500
125711
D
Non-Qualified Stock Option (right to buy)
3.88
2022-01-03
4
M
0
10000
0.0
D
2027-09-19
Common Stock
10000
115711
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 1,040 shares; $46.00-$46.99 - 3,779 shares; $47.00-$47.99 - 15,181 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 775 shares; $46.00-$46.99 - 1,691 shares; $47.00-$47.99 - 10,034 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 700 shares; $46.00-$46.99 - 1,784 shares; $47.00-$47.99 - 7,366; $48.00 - $48.99 - 150 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option vested in 48 equal monthly installments beginning on October 19, 2017.
By: John L Brottem For: Leslie Trigg
2022-01-04